<DOC>
	<DOCNO>NCT00197860</DOCNO>
	<brief_summary>The purpose study show vaccination autologous dendritic cell pulse peptide tumor lysate combination adjuvant cytokine induce measurable immune response patient metastatic renal cell carcinoma , evaluate clinical effect ( objective response rate ) vaccination regime .</brief_summary>
	<brief_title>Dendritic Cell Based Therapy Renal Cell Carcinoma</brief_title>
	<detailed_description>Eligible patient receive vaccination tumor antigen pulse autologous monocyte-derived mature dendritic cell fix interval . The dendritic cell generate leukapheresis product frozen antigen loading . HLA A2 positive patient treat PADRE oncopeptide pulsed DC ; survivin telomerase peptide . HLA A2 negative patient treat KLH tumorlysate pulse DC ; autologous allogeneic . Each patient give 6 immunization least 5x106 peptide/lysate pulse autologous DC . Vaccination 1-4 give weekly 4-6 2-week interval . Those patient exhibit stable disease , partial response complete response 6 injection give 4 vaccination 2-week interval . The vaccine apply intradermal injection near inguinal region . IL-2 2 MIU s.c. day 2-6 Thymosin alpha 1 ( ZadaxinÂ® , SciClone ) 1,6 mg s.c. twice week used adjuvant . Scans re-staging test perform schedule interval throughout study .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Renal Cell</mesh_term>
	<criteria>Histologically proven progressive metastatic locally advanced renal cell carcinoma No standard treatment indicated Age : &gt; 18 WHOPerformance Status 01 At least tone measurable tumor lesion accord RECIST criterion . Life expectancy 3 month Acceptable CBC blood chemistry result Written inform consent Patients history neoplastic disease le 5 year ago ( except treat carcinoma situ cervix basal/squamous cell carcinoma skin ) . Patients metastatic disease central nervous system ( CNS ) . Patients significant illness include severe allergy , asthma , angina pectoris congestive heart failure . Patients acute chronic infection include HIV , hepatitis tuberculosis . Patients pregnant . Patients receive antineoplastic therapy include chemotherapy immunotherapy le 4 week begin trial . Patients receive corticosteroid immunosuppressive agent . Baseline serum LDH great 4 time upper limit normal . Patients active autoimmune disease lupus erythematosus , rheumatoid arthritis thyroiditis .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>dendritic cell</keyword>
	<keyword>vaccine</keyword>
	<keyword>renal cell carcinoma</keyword>
</DOC>